Study suggests limits on opioid dosage may not reduce overdoses

09/17/2013 | Medscape (free registration)

Restricting daily morphine dosages to 100 mg may not be an effective strategy to reduce overdoses, according to Purdue Pharma research released at PAINWeek 2013. The study, which cited age, sedative use and lack of a recent opioid prescription as factors in overdose risk, followed recommendations from Physicians for Rational Opioid Prescribing that included limiting doses for noncancer pain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Abbott
Santa Clara, CA
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA